Back

Summit Therapeutics Stock Predictions

Free Stock Analysis Report: See The True Value of Any Stock

Analyze Any Stock Free

Sell

SMMT
Summit Therapeutics

Last Price:

$16.66

Seasonality Move:

7.78%

7 Day Trial

ALL ACCESS PASS

$ 7

Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings

Analyze Any Stock Free

Summit Therapeutics Stock Forecast

Over the next 52 weeks, Summit Therapeutics has on average historically risen by 75.5% based on the past 9 years of stock performance.
Summit Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Is Summit Therapeutics Stock Undervalued?

The current Summit Therapeutics [SMMT] share price is $18.18. The Score for SMMT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
SMMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Summit Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Summit Therapeutics has on average historically risen by 75.5% based on the past 9 years of stock performance.

Summit Therapeutics Stock Rating

Sell

Summit Therapeutics (SMMT) is a Sell

Is Summit Therapeutics overpriced?

Summit Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%

Summit Therapeutics Stock Price History

Is SMMT stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

smmttx.com

52-Week Data

52-Week High:

33.89

52-Week Low:

2.10

Prediction Charts

Market Cap:

13.4B

Price in USD:

18.18

Volume:

1.7M

Beta:

-0.23

Technical Analysis

SMA50:

18.80

SMA100:

19.12

SMA200:

12.96

52-Wk Change:

486.29%

Stock Predictions

Is Summit Therapeutics stock public?

Yes, Summit Therapeutics is a publicly traded company.
What is the Summit Therapeutics stock quote today?

The Summit Therapeutics stock price is 18.18 USD today.
How to buy Summit Therapeutics stock online?

You can buy Summit Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-20	18.02	17.87	18.60	17.71
Dec-23	17.97	18.67	18.90	17.61
Dec-24	18.88	19.00	19.08	18.33
Dec-26	18.75	19.28	19.55	18.63
Dec-27	19.01	18.21	19.30	17.98
Dec-30	17.89	17.89	18.15	17.53
Dec-31	17.94	17.85	18.31	17.17
Jan-2	17.97	18.35	18.89	17.75
Jan-3	18.25	18.24	18.61	18.06
Jan-6	18.33	17.47	18.55	17.41
Jan-7	17.62	18.16	18.21	17.37
Jan-8	18.45	18.82	19.39	18.10
Jan-10	18.58	17.85	18.91	16.72
Jan-13	17.50	18.18	18.32	17.03

Summit Therapeutics Earnings

Summit Therapeutics Earnings Report: Per Share Summit Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Summit Therapeutics Forecast Revenue Growth

Summit Therapeutics Stock Analysis: Historical quarterly revenues per share for Summit Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.16 per share.

* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.